医疗
The Emperor of All Maladies 豆瓣
9.0 (14 个评分) 作者: Siddhartha Mukherjee Scribner 2010 - 11
Starred Review. Mukherjee's debut book is a sweeping epic of obsession, brilliant researchers, dramatic new treatments, euphoric success and tragic failure, and the relentless battle by scientists and patients alike against an equally relentless, wily, and elusive enemy. From the first chemotherapy developed from textile dyes to the possibilities emerging from our understanding of cancer cells, Mukherjee shapes a massive amount of history into a coherent story with a roller-coaster trajectory: the discovery of a new treatment--surgery, radiation, chemotherapy--followed by the notion that if a little is good, more must be better, ending in disfiguring radical mastectomy and multidrug chemo so toxic the treatment ended up being almost worse than the disease. The first part of the book is driven by the obsession of Sidney Farber and philanthropist Mary Lasker to find a unitary cure for all cancers. (Farber developed the first successful chemotherapy for childhood leukemia.) The last and most exciting part is driven by the race of brilliant, maverick scientists to understand how cells become cancerous. Each new discovery was small, but as Mukherjee, a Columbia professor of medicine, writes, "Incremental advances can add up to transformative changes." Mukherjee's formidable intelligence and compassion produce a stunning account of the effort to disrobe the "emperor of maladies." (Nov.) (c)
Copyright © Reed Business Information, a division of Reed Elsevier Inc. All rights reserved.
2024年7月28日 已读
去年读了个开头就没继续,今年找到了有声书所以决定读完。经常看到别人说如果读一本书的前一百页不能吸引你的话就可以止损放弃了,没必要死撑——这是真理。

我对癌症和死亡的问题的关心起于《最好的告别》,同样是医生写作,是一本给我带来很多思考和启示的书。《众病之王》的问题在于没有故事主线,作者就像是堆积写作材料一样把自己了解的癌症历史事无巨细而无组织地写出来,还很喜欢给历史故事加注解,描写人物的性格经历和灵光一现的想法,非常典型的维基百科写法真的让我无法忍受。

Goodreads上的热评完整地表达了我的想法:What has the author accomplished in this book? I think he has written an overly detailed^, partially complete^^, suboptimally organized^^^ account of the evolution of our understanding of cancer and the development of treatment options to counteract it.

^: "overly detailed" - to give just one example, was it really necessary to devote a page and a half to reviewing Lister's introduction of antiseptics? And in a book which appeared to be focused on diagnostic and therapeutic options, why devote 40 pages to the link between smoking and cancer with the emphasis firmly on the legal and regulatory aspects?
^^: eye-glazing detail about kinase inhibitors, but nothing about anti-angiogenesis agents (Avastin was approved around 2003, as I recall, so it's clearly well within the time horizon)
^^^: a person could get whiplash from all the zipping up and back down the historical timeline, for no obvious reason.
科普 医疗 科学